Why the study?
Timely intervention reduces ACS mortality, but convenient biomarkers for diagnosing ACS and establishing clinical significance are needed.
Does serum miR-30c-5p expression predict disease onset and short-term prognosis in patients with acute coronary syndrome?
Population
173 subjects (98 ACS subjects and 65 healthy subjects)
Comparison
ACS subjects vs healthy subjects
Design
Observational cohort study
Authors
Loading...
Should not yet change ACS diagnosis or short-term risk stratification; leaves open incremental value beyond troponin in larger prospective studies.
Does serum miR-30c-5p expression predict disease onset and short-term prognosis in patients with acute coronary syndrome?
Downregulation of serum miR-30c-5p serves as a potential diagnostic biomarker for acute coronary syndrome and an independent predictor of short-term major adverse cardiovascular events.
Chang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: